BioVoice News August 2017 Issue 3 Volume 2 | Page 97

However, Mrs Patel ruled out any proposal to make carrier testing compulsory for relatives of thalassemia patients as it should be voluntary and not cause stigmatization of the family. “Awareness programme on thalassemia are being conducted by several State Governments,” she said. HEALTHQUADV RAISES INR 750 MILLION TO SUPPORT THEMATIC INDIAN HEALTHCARE FIRMS Healthquad, India’s leading specialist healthcare focused venture capital fund has achieved its final close with total commitment of INR 750 million for investing in thematic and disruptive healthcare business models in India. The Fund is also the first early stage investment vehicle by the leading healthcare private equity investors, Dr Amit Varma, Abrar Mir and Charles Antione Janssen. The Fund targets to invest around INR 4 billion in healthcare companies that have the potential to disrupt the healthcare landscape by dramatically improving the productivity, affordability and accessibility of healthcare through differentiated and innovative solutions. The Fund’s investment strategy targets five key healthcare sub-sectors including Healthcare Delivery Services, Life-Sciences, Medical Devices & Technology, Healthcare IT and Associated Healthcare Services. It is looking to invest in 8-10 companies. The minister further mentioned that the guidelines provide for screening of every pregnant woman during ANC, premarital counselling at the college level and one-time screening for variant anaemia for all children in class VIII. BIRAC’S GRAND CHALLENGES OPENS UP FOR PROPOSALS FROM HEALTH INNOVATORS The Grand Challenges Explorations (GCE) - India program funds exploratory ideas from within India, which create pathways for drug discovery, vaccine development, advancement in health technologies and delivery systems that can be made available to people from all socio-economic strata. BIOVOICENEWS.COM 97